balchem corp. - BCPC

BCPC

Close Chg Chg %
173.72 -0.56 -0.32%

Closed Market

173.16

-0.56 (0.32%)

Volume: 178.40K

Last Updated:

Feb 6, 2026, 4:00 PM EDT

Company Overview: balchem corp. - BCPC

BCPC Key Data

Open

$174.98

Day Range

173.13 - 176.41

52 Week Range

139.17 - 177.40

Market Cap

$5.64B

Shares Outstanding

32.39M

Public Float

32.23M

Beta

0.97

Rev. Per Employee

N/A

P/E Ratio

38.03

EPS

$4.61

Yield

55.26%

Dividend

$0.96

EX-DIVIDEND DATE

Dec 23, 2025

SHORT INTEREST

N/A

AVERAGE VOLUME

158.08K

 

BCPC Performance

1 Week
 
1.76%
 
1 Month
 
8.04%
 
3 Months
 
13.50%
 
1 Year
 
8.04%
 
5 Years
 
49.84%
 

BCPC Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 4
Full Ratings ➔

About balchem corp. - BCPC

Balchem Corp. provides marketing of specialty performance ingredients and products. It operates through the following segments: Human Nutrition and Health, Animal Nutrition and Health and Specialty Products. The Human Nutrition and Health segment supplies ingredients in the food and beverage industry, providing customized solutions in powder, solid and liquid flavor delivery systems, spray dried emulsified powder systems, and cereal systems. The Animal Nutrition and Health segment consists of nutritional products derived from microencapsulation and chelation technologies in addition to basic choline chloride. The Specialty Products segment offers Ethylene oxide for the health care industry. The company was founded in January 1967 and is headquartered in Montvale, NJ.

BCPC At a Glance

Balchem Corp.
5 Paragon Drive
Montvale, New Jersey 07645
Phone 1-845-326-5600 Revenue 953.68M
Industry Food: Specialty/Candy Net Income 128.48M
Sector Consumer Non-Durables 2024 Sales Growth 3.387%
Fiscal Year-end 12 / 2025 Employees 1,361
View SEC Filings

BCPC Valuation

P/E Current 38.026
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 41.509
Price to Sales Ratio 5.592
Price to Book Ratio 4.611
Price to Cash Flow Ratio 29.30
Enterprise Value to EBITDA 23.704
Enterprise Value to Sales 5.758
Total Debt to Enterprise Value 0.038

BCPC Efficiency

Revenue/Employee 700,722.998
Income Per Employee 94,397.502
Receivables Turnover 7.97
Total Asset Turnover 0.59

BCPC Liquidity

Current Ratio 1.99
Quick Ratio 1.16
Cash Ratio 0.314

BCPC Profitability

Gross Margin 35.253
Operating Margin 19.316
Pretax Margin 17.454
Net Margin 13.471
Return on Assets 7.955
Return on Equity 11.659
Return on Total Capital 9.461
Return on Invested Capital 9.396

BCPC Capital Structure

Total Debt to Total Equity 18.092
Total Debt to Total Capital 15.32
Total Debt to Total Assets 12.962
Long-Term Debt to Equity 17.803
Long-Term Debt to Total Capital 15.075
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Balchem Corp. - BCPC

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
799.02M 942.36M 922.44M 953.68M
Sales Growth
+13.56% +17.94% -2.11% +3.39%
Cost of Goods Sold (COGS) incl D&A
555.85M 661.91M 620.38M 617.48M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
45.76M 51.30M 54.41M 47.45M
Depreciation
20.67M 24.03M 26.37M 28.21M
Amortization of Intangibles
25.09M 27.27M 28.04M 19.24M
COGS Growth
+15.86% +19.08% -6.27% -0.47%
Gross Income
243.17M 280.45M 302.06M 336.21M
Gross Income Growth
+8.61% +15.33% +7.70% +11.31%
Gross Profit Margin
+30.43% +29.76% +32.75% +35.25%
2021 2022 2023 2024 5-year trend
SG&A Expense
115.22M 132.50M 123.95M 152.00M
Research & Development
13.52M 12.19M 15.05M 16.79M
Other SG&A
101.70M 120.30M 108.90M 135.20M
SGA Growth
+6.24% +14.99% -6.45% +22.63%
Other Operating Expense
- - - -
-
Unusual Expense
448.00K 2.77M 18.91M 1.30M
EBIT after Unusual Expense
127.50M 145.19M 159.19M 182.91M
Non Operating Income/Expense
2.44M 1.08M 1.80M 72.00K
Non-Operating Interest Income
- 2.26M 2.25M 1.12M
Equity in Earnings of Affiliates
(557.00K) (559.00K) (509.00K) (489.00K)
Interest Expense
4.71M 12.52M 23.73M 16.53M
Interest Expense Growth
-29.80% +165.61% +89.58% -30.36%
Gross Interest Expense
4.71M 12.52M 23.73M 16.53M
Interest Capitalized
- - - -
-
Pretax Income
125.23M 133.75M 137.26M 166.45M
Pretax Income Growth
+17.68% +6.80% +2.63% +21.27%
Pretax Margin
+15.67% +14.19% +14.88% +17.45%
Income Tax
29.13M 28.38M 28.72M 37.98M
Income Tax - Current - Domestic
28.68M 30.39M 31.71M 34.38M
Income Tax - Current - Foreign
7.55M 7.10M 7.63M 10.38M
Income Tax - Deferred - Domestic
(4.07M) (8.89M) (8.34M) (3.59M)
Income Tax - Deferred - Foreign
(3.04M) (215.00K) (2.29M) (3.19M)
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
(557.00K) (559.00K) (509.00K) (489.00K)
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
96.10M 105.37M 108.54M 128.47M
Minority Interest Expense
- - - -
-
Net Income
96.10M 105.37M 108.54M 128.47M
Net Income Growth
+13.57% +9.64% +3.01% +18.36%
Net Margin Growth
+12.03% +11.18% +11.77% +13.47%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
96.10M 105.37M 108.54M 128.47M
Preferred Dividends
- - - -
-
Net Income Available to Common
96.10M 105.37M 108.54M 128.47M
EPS (Basic)
2.9832 3.2908 3.3806 3.9736
EPS (Basic) Growth
+13.43% +10.31% +2.73% +17.54%
Basic Shares Outstanding
32.22M 32.02M 32.11M 32.33M
EPS (Diluted)
2.9415 3.2528 3.3451 3.9267
EPS (Diluted) Growth
+12.98% +10.58% +2.84% +17.39%
Diluted Shares Outstanding
32.67M 32.39M 32.45M 32.72M
EBITDA
173.71M 199.26M 232.51M 231.66M
EBITDA Growth
+5.64% +14.71% +16.69% -0.36%
EBITDA Margin
+21.74% +21.14% +25.21% +24.29%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 200.667
Number of Ratings 4 Current Quarters Estimate 1.235
FY Report Date 03 / 2026 Current Year's Estimate 5.107
Last Quarter’s Earnings 1.175 Median PE on CY Estimate N/A
Year Ago Earnings 4.713 Next Fiscal Year Estimate 5.22
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 2 2 3 1
Mean Estimate 1.24 1.27 5.11 5.22
High Estimates 1.25 1.30 5.17 5.22
Low Estimate 1.22 1.24 4.99 5.22
Coefficient of Variance 1.72 3.34 1.98 N/A

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 2 2 2
OVERWEIGHT 1 1 1
HOLD 1 1 0
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Overweight Overweight Buy

Insider Actions for Balchem Corp. - BCPC

Date Name Shares Transaction Value
Jul 29, 2025 Hatsuki Miyata EVP, CLO, & Secretary 6,189 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $148.82 per share 921,046.98
Feb 13, 2025 William A. Backus VP & Chief Accounting Officer 4,678 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $159.39 per share 745,626.42
Feb 13, 2025 Theodore L. Harris Chairman, President & CEO; Director 61,637 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $159.39 per share 9,824,321.43
Feb 13, 2025 Michael Sestrick SVP & Chief Technology Officer 3,791 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $159.39 per share 604,247.49
Feb 13, 2025 Martin Bengtsson EVP & Chief Financial Officer 18,168 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $159.39 per share 2,895,797.52
Feb 13, 2025 Job van Gunsteren SVP and GM, Specialty Products 8,282 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $159.39 per share 1,320,067.98
Feb 13, 2025 Martin L. Reid SVP Chief Supply Chain Officer 5,761 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $159.39 per share 918,245.79
Feb 13, 2025 Michael Bent Tignor SVP & Chief HR Officer 6,782 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $159.39 per share 1,080,982.98

Balchem Corp. in the News